Expertise in
39
conditions

Dr. Shannon Schmidt

Hematology | Oncology
Thedacare Regional Medical Center-Appleton Inc.
2500 E Capitol Dr, 
Appleton, WI 
17 Years of Experience
Expertise in
39
conditions
Thedacare Regional Medical Center-Appleton Inc.
2500 E Capitol Dr, 
Appleton, WI 

Overview

Shannon Schmidt is a Hematologist and an Oncologist in Appleton, Wisconsin. Dr. Schmidt has been practicing medicine for over 17 years is highly rated in 39 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, B-Cell Lymphoma, Angiosarcoma, and Bone Marrow Aspiration.

Her clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Medical College Of Wisconsin, 2009

Specialties

Hematology
Oncology

Licenses

Internal Medicine in WI

Hospital Affiliations

Thedacare Regional Medical Center - Appleton Inc
Thedacare Regional Med Ctr - Neenah
Thedacare Medical Center-Waupaca

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Common Ground Healthcare
  • OTHER COMMERCIAL
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Network Health
  • HMO
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Thedacare Regional Medical Center-Appleton Inc.
2500 E Capitol Dr, Appleton, WI 54911
Other Locations
ThedaCare Physicians Neenah
333 N Green Bay Rd, Neenah, WI 54956

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Drug, Procedure, Radiation, Other
Study Drug: Olaparib
Study Phase: Phase 2
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Procedure, Biological, Drug, Radiation
Study Drugs: Docetaxel, Nab-Paclitaxel, Paclitaxel, Pertuzumab, Trastuzumab, Trastuzumab Emtansine
Study Phase: Phase 2
The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
Enrollment Status: Active_not_recruiting
Publish Date: October 29, 2025
Intervention Type: Other, Biological, Drug
Study Drugs: Trastuzumab Emtansine, Tucatinib
Study Phase: Phase 3
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
39
conditions
Dr. Yazhini Vallatharasu
Hematology | Oncology
Expertise in
39
conditions
Dr. Yazhini Vallatharasu
Hematology | Oncology

Thedacare Regional Medical Center-Appleton Inc.

2500 E Capitol Dr, 
Appleton, WI 
 (12.9 miles away)
920-364-3600
Languages Spoken:
English
See accepted insurances

Yazhini Vallatharasu is a Hematologist and an Oncologist in Appleton, Wisconsin. Dr. Vallatharasu is highly rated in 39 conditions, according to our data. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Multiple Myeloma, Paroxysmal Cold Hemoglobinuria, and Lung Cancer.

Expertise in
27
conditions
Dr. Alexander Starr
Hematology | Oncology
Expertise in
27
conditions
Dr. Alexander Starr
Hematology | Oncology

ThedaCare Regional Cancer Center

2500 E Capitol Dr # 2600, 
Appleton, WI 
 (13.5 miles away)
920-364-3600
Languages Spoken:
English
See accepted insurances

Alexander Starr is a Hematologist and an Oncologist in Appleton, Wisconsin. Dr. Starr is highly rated in 27 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Myelodysplastic Syndrome (MDS), Lung Cancer, and Bone Marrow Aspiration.

Expertise in
18
conditions
Dr. Qiaofang Chen
Hematology | Oncology
Expertise in
18
conditions
Dr. Qiaofang Chen
Hematology | Oncology

Thedacare Regional Medical Center-Appleton Inc.

2500 E Capitol Dr, 
Appleton, WI 
 (12.9 miles away)
920-364-3600
Languages Spoken:
English
See accepted insurances

Qiaofang Chen is a Hematologist and an Oncologist in Appleton, Wisconsin. Dr. Chen is highly rated in 18 conditions, according to our data. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma.

Frequently Asked Questions about Dr. Shannon Schmidt

How do I make an appointment with Dr. Shannon Schmidt?

You can book an appointment with Dr. Shannon Schmidt by calling their office at 920-364-3600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shannon Schmidt a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shannon Schmidt is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shannon Schmidt specialize in?

While Dr. Shannon Schmidt is a Hematology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and B-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Shannon Schmidt accept my insurance?

Dr. Shannon Schmidt accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 920-364-3600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schmidt's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 29 Advanced Conditions
    View All 136 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile